Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Glaxo Wellcome

Glaxo Wellcome and SmithKline Beecham have won approval from the European Commission for their merger, provided they dispose of products with EU sales of £50m.

Glaxo Wellcome is to merge with SmithKline Beecham to create a combined pharmaceuticals group with market capitalisation of £107bn, and the operational headquarters will be moved to the US.

Glaxo Wellcome has resumed negotiations for a merger with SmithKline Beecham, which could lead to the creation of the world's largest pharmaceuticals group.

Glaxo Wellcome and SmithKline Beecham are planning a £100bn merger to create the largest pharmaceuticals company in the world, thereby putting an end to SmithKline's plans to merge with American Home Products.

Glaxo Wellcome is acquiring an 80% stake in Polfa Poznan, the Polish drugs company, for £132m as part of a strategy to expand in emerging markets.

Glaxo Wellcome is acquiring full control of Nippon Glaxo, its joint venture with Shin Nihon Jitsugyo, for £360m.

Glaxo Wellcome is selling its stake in Warner Wellcome to Warner Lambert for $1.05bn.

Glaxo is looking for a buyer for Hazeline, its East Asian cosmetics operation.